Literature DB >> 3891655

The rapidly growing mycobacteria--Mycobacterium fortuitum and Mycobacterium chelonei.

T H Brown.   

Abstract

In summary, rapidly growing mycobacteria, M. fortuitum and M. chelonei, are pathogens of increasing importance which are often hospital-acquired and can infect patients with iatrogenic immunosuppression. They readily grow on routine mycobacterial culture media and must be distinguished from non-pathogenic rapidly growing species and slowly growing mycobacteria. Widely distributed in nature, they are often present in hospital environments, especially in water. Compared to M. tuberculosis they are weak pathogens, and infected patients are not considered contagious. Disease is probably acquired from environmental sources by direct entry of the organisms through traumatized skin or mucous membranes or by aspiration into previously abnormal lungs. They are usually resistant to antituberculous agents but are susceptible to several commonly used antibacterial agents. Treatment generally requires one or more active antibiotics plus adjunctive surgery in many cases. Prevention of nosocomial infection lies in proper disinfection of potentially contaminated medical devices and elimination of contaminated water.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3891655     DOI: 10.1017/s0195941700061762

Source DB:  PubMed          Journal:  Infect Control        ISSN: 0195-9417


  9 in total

Review 1.  Agents of newly recognized or infrequently encountered mycobacterial diseases.

Authors:  L G Wayne; H A Sramek
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

2.  Mycobacterial contamination of fibreoptic bronchoscopes.

Authors:  N M Brown; E A Hellyar; J E Harvey; D S Reeves
Journal:  Thorax       Date:  1993-12       Impact factor: 9.139

3.  Application of a broad-range resequencing array for detection of pathogens in desert dust samples from Kuwait and Iraq.

Authors:  Tomasz A Leski; Anthony P Malanoski; Michael J Gregory; Baochuan Lin; David A Stenger
Journal:  Appl Environ Microbiol       Date:  2011-05-13       Impact factor: 4.792

4.  Efficacy of chemical dosing methods for isolating nontuberculous mycobacteria from water supplies of dialysis centers.

Authors:  L A Carson; L B Cusick; L A Bland; M S Favero
Journal:  Appl Environ Microbiol       Date:  1988-07       Impact factor: 4.792

5.  Misidentification of Mycobacterium fortuitum in an immunocompetent patient presenting with a unilateral neck mass.

Authors:  Todd Kanzara; Andy Hall; Simon Namnyak; Tony Owa
Journal:  BMJ Case Rep       Date:  2014-04-17

6.  Complete genome sequence of Mycobacterium fortuitum subsp. fortuitum type strain DSM46621.

Authors:  Yung S Ho; Sabir A Adroub; Fajr Aleisa; Hanan Mahmood; Ghofran Othoum; Fahad Rashid; Manal Zaher; Shahjahan Ali; Wilbert Bitter; Arnab Pain; Abdallah M Abdallah
Journal:  J Bacteriol       Date:  2012-11       Impact factor: 3.490

Review 7.  Crohn's disease and the mycobacterioses: a review and comparison of two disease entities.

Authors:  R J Chiodini
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

Review 8.  Clinical and laboratory aspects of the diagnosis and management of cutaneous and subcutaneous infections caused by rapidly growing mycobacteria.

Authors:  R J Kothavade; R S Dhurat; S N Mishra; U R Kothavade
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-09       Impact factor: 3.267

9.  Evaluation of Whole-Genome Sequencing for Mycobacterial Species Identification and Drug Susceptibility Testing in a Clinical Setting: a Large-Scale Prospective Assessment of Performance against Line Probe Assays and Phenotyping.

Authors:  T Phuong Quan; Zharain Bawa; Dona Foster; Tim Walker; Carlos Del Ojo Elias; Priti Rathod; Zamin Iqbal; Phelim Bradley; Janet Mowbray; A Sarah Walker; Derrick W Crook; David H Wyllie; Timothy E A Peto; E Grace Smith
Journal:  J Clin Microbiol       Date:  2018-01-24       Impact factor: 5.948

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.